|
| 37482523 | Case Series of Men with the Germline APC I1307K variant and Treatment-Emergent Neuroendocrine Prostate Cancer. | Clin Genitourin Cancer | 2024 |
| 37482523 | Case Series of Men with the Germline APC I1307K variant and Treatment-Emergent Neuroendocrine Prostate Cancer. | Clin Genitourin Cancer | 2024 |
| 37163349 | PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation. | Blood Adv | 2023 |
| 37589763 | Factors associated with diagnostic ultrasound for midgut volvulus and relevance of the non-diagnostic examination. | Pediatr Radiol | 2023 |
| 37163349 | PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation. | Blood Adv | 2023 |
| 37097450 | Crohn's disease phenotype analysis with iodine density from dual-energy CT enterography. | Abdom Radiol (NY) | 2023 |
| 37589763 | Factors associated with diagnostic ultrasound for midgut volvulus and relevance of the non-diagnostic examination. | Pediatr Radiol | 2023 |
| 37097450 | Crohn's disease phenotype analysis with iodine density from dual-energy CT enterography. | Abdom Radiol (NY) | 2023 |
| 35007321 | A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia. | Blood | 2022 |
| 35471731 | Adherence to guidelines at the patient- and hospital-levels is associated with improved overall survival in patients with gastric cancer. | J Surg Oncol | 2022 |
| 36450385 | Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma. | J Immunother Cancer | 2022 |
| 35007321 | A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia. | Blood | 2022 |
| 35471731 | Adherence to guidelines at the patient- and hospital-levels is associated with improved overall survival in patients with gastric cancer. | J Surg Oncol | 2022 |
| 36450385 | Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma. | J Immunother Cancer | 2022 |
| 34166841 | Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's. | Contemp Clin Trials | 2021 |
| 35734207 | Elevated Levels of Urinary Biomarkers TIMP-2 and IGFBP-7 Predict Acute Kidney Injury in Neonates after Congenital Heart Surgery. | J Pediatr Intensive Care | 2021 |
| 34166841 | Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's. | Contemp Clin Trials | 2021 |
| 34224367 | Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma. | Mol Cancer Ther | 2021 |
| 34100025 | Impaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL Patients. | medRxiv | 2021 |
| 35734207 | Elevated Levels of Urinary Biomarkers TIMP-2 and IGFBP-7 Predict Acute Kidney Injury in Neonates after Congenital Heart Surgery. | J Pediatr Intensive Care | 2021 |
| 34224367 | Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma. | Mol Cancer Ther | 2021 |
| 34100025 | Impaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL Patients. | medRxiv | 2021 |
| 32878618 | Value of metalloproteinases in predicting COPD in heavy urban smokers. | Respir Res | 2020 |
| 32019876 | Pharmacodynamics of natalizumab extended interval dosing in MS. | Neurol Neuroimmunol Neuroinflamm | 2020 |
| 32014615 | A Prospective Trial to Compare Deep Inspiratory Breath Hold With Prone Breast Irradiation. | Pract Radiat Oncol | 2020 |
| 32878618 | Value of metalloproteinases in predicting COPD in heavy urban smokers. | Respir Res | 2020 |
| 32889595 | Comparison of Clinical Measures Among Interstitial Lung Disease (ILD) Patients with Usual Interstitial Pneumonia (UIP) Patterns on High-Resolution Computed Tomography. | Lung | 2020 |
| 32019876 | Pharmacodynamics of natalizumab extended interval dosing in MS. | Neurol Neuroimmunol Neuroinflamm | 2020 |
| 32014615 | A Prospective Trial to Compare Deep Inspiratory Breath Hold With Prone Breast Irradiation. | Pract Radiat Oncol | 2020 |
| 32889595 | Comparison of Clinical Measures Among Interstitial Lung Disease (ILD) Patients with Usual Interstitial Pneumonia (UIP) Patterns on High-Resolution Computed Tomography. | Lung | 2020 |
| 30668266 | Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis. | Leuk Lymphoma | 2019 |
| 30205231 | Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study. | Biol Blood Marrow Transplant | 2019 |
| 31157195 | Plasma Zonulin Levels in Childhood Nephrotic Syndrome. | Front Pediatr | 2019 |
| 31363161 | A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis. | Leukemia | 2019 |
| 30668266 | Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis. | Leuk Lymphoma | 2019 |
| 31515290 | Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing. | Neurology | 2019 |
| 31515250 | Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea. | Blood | 2019 |
| 31296256 | Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients. | J Immunother Cancer | 2019 |
| 30205231 | Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study. | Biol Blood Marrow Transplant | 2019 |
| 31296256 | Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients. | J Immunother Cancer | 2019 |
| 31515290 | Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing. | Neurology | 2019 |
| 31515250 | Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea. | Blood | 2019 |
| 31363161 | A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis. | Leukemia | 2019 |
| 31157195 | Plasma Zonulin Levels in Childhood Nephrotic Syndrome. | Front Pediatr | 2019 |
| 28746058 | Rapid Number Naming and Quantitative Eye Movements May Reflect Contact Sport Exposure in a Collegiate Ice Hockey Cohort. | J Neuroophthalmol | 2018 |
| 28746058 | Rapid Number Naming and Quantitative Eye Movements May Reflect Contact Sport Exposure in a Collegiate Ice Hockey Cohort. | J Neuroophthalmol | 2018 |
| 29859789 | Hypofractionated Whole-Breast Irradiation in Women Less Than 50Â Years Old Treated on 4 Prospective Protocols. | Int J Radiat Oncol Biol Phys | 2018 |
| 30233806 | Serum albumin at 1 year predicts long-term renal outcome in lupus nephritis. | Lupus Sci Med | 2018 |
| 30563881 | Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms. | Blood Adv | 2018 |
| 29476019 | Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer. | Clin Cancer Res | 2018 |